Big Pharma’s miracle injections are under fire again as new research uncovers how Ozempic and similar GLP-1 drugs could be setting users up for severe long-term health traps.
A new study suggests that slamming the brakes on appetite, these medications risk starving the body of essential nutrients, paving the way for elevated dangers of heart problems, chronic illnesses, and even certain cancers.
It’s another stark reminder of how the medical-industrial complex prioritizes profits over genuine wellness, leaving Americans to pay the price.
YouTube version of the video here (Not embeddable).
In a landscape where synthetic fixes are pushed over real food and lifestyle reforms, this revelation is stark. With millions hooked on these jabs, the findings demand scrutiny—especially as the media downplays the risks while pushing the hype.
A recent review by Australia’s Hunter Medical Research Institute and the University of Newcastle analyzed 41 randomized controlled trials on popular GLP-1/GIP medications spanning the last 17 years.
Shockingly, only two studies tracked dietary intake among adults, and one remains unpublished. This glaring “blind spot” highlights how little we know about the nutritional impacts of these drugs, despite their skyrocketing use.
The core issue is appetite suppression. While users shed weight, they often consume far fewer calories and nutrients, leading to deficiencies that can trigger inflammation, metabolic chaos, and heightened vulnerability to serious conditions.
As the researchers warn, inadequate nutrition “can increase the risk of cardiovascular disease, metabolic complications, inflammation and long-term chronic conditions, including some cancers.”
At least half a million Australians are jabbing these drugs monthly, amid ongoing shortages. In the U.S., the numbers are even higher, with Ozempic and its cousins like Mounjaro becoming go-to prescriptions for obesity and diabetes.
Separate studies have already flagged mixed signals on direct cancer links. A 2025 JAMA Oncology paper found GLP-1 drugs associated with an overall 17% lower cancer risk, but with a potential uptick in kidney cancer.
Yet this new Australian work shifts focus to indirect threats via malnutrition, underscoring how Big Pharma’s rush to market often ignores holistic health data.
HHS Secretary Robert F. Kennedy Jr., a vocal critic of pharmaceutical overreach and champion of the Make America Healthy Again (MAHA) initiative, has long sounded alarms on drugs like Ozempic.
RFK Jr. says he still believes there are serious risks to taking weight loss drugs like Ozempic.
— End Tribalism in Politics (@EndTribalism) November 10, 2025
Martha MacCallum: “So you believe that Ozempic and Wegovy and these drugs, that they are safe for long-term use for Americans?”
RFK Jr: “I didn’t say that.”
“I think every… pic.twitter.com/k8ekj0jmfG
RFK is against Ozempic, says government can just give people three organic meals a day.
— Richard Hanania (@RichardHanania) August 29, 2024
I can’t get over how wrong he is on everything. Unique combination of brain dead hippie, rightoid, and airhead celebrity all in one. pic.twitter.com/MYv4XYCY0U
In a 2024 appearance on Greg Gutfeld’s show, RFK Jr. dismissed hype around the jab’s supposed addiction-curbing benefits, stating: “The EU right now investigating Ozempic for suicidal ideation. It may be that the drug suppresses all reward pathways so makes you want do everything less.”
RFK Jr: “No,” Ozempic is not going to Make America Healthy Again.
— MAHA PAC? (@MAHA_PAC) October 19, 2024
“There’s a huge push to sell this to the American public … They make this drug in Denmark, and in Denmark, they DO NOT recommend it for diabetes or for obesity. They recommend dietary and behavioral changes.… pic.twitter.com/t4iUASSRla
He slammed the cost and inefficacy, adding: “We’re spending sixteen hundred dollars on these drugs… That alone costs three trillion dollars. If you spend about one fifth giving good food to every man, woman and child in our country, we could solve the obesity diabetes epidemic overnight a tiny fraction of the cost.”
RFK Jr. accused manufacturers of targeting gullible Americans: “They make this drug in Denmark but do not recommend it for diabetes or or for obesity, they recommend dietary and behavioral changes…They’re counting on selling it to Americans because we are so stupid and so addicted to drugs.”
RFK JR : "Today, over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 a month. Most of these members have taken money from the manufacturer of that product, a European company called Novo Nordisk. As everyone knows, once a drug is approved for… pic.twitter.com/vlGPrw13mA
— Based Jessica (@RealJessica) December 2, 2025
This latest Ozempic warning aligns perfectly with MAHA’s mission to combat chronic disease epidemics through natural, sustainable means—potentially addressing nutritional deficiencies head-on by reforming food systems and exposing drug industry frauds.
These findings expose the hypocrisy of a system that peddles quick fixes while ignoring root causes like processed foods and sedentary lifestyles. Users report real weight loss, but at what cost? Lawsuits over side effects like gastrointestinal horrors are mounting, and now nutritional risks add fuel to the fire.
Your support is crucial in helping us defeat mass censorship. Please consider donating via Locals or check out our unique merch. Follow us on X @ModernityNews.
More news on our radar
